Lindsay Ann Rankin, PT, DPT | |
2785 Eagle Dr Apt G106, Ammon, ID 83406-5763 | |
(801) 602-2651 | |
Not Available |
Full Name | Lindsay Ann Rankin |
---|---|
Gender | Female |
Speciality | Physical Therapy |
Experience | 11 Years |
Location | 2785 Eagle Dr Apt G106, Ammon, Idaho |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225401904 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Manual Solutions Pllc | 0244427292 | 5 |
News Archive
Patients who are otherwise completely unable to communicate can answer yes or no questions within seconds with the help of a simple system-consisting of just a laptop and camera-that measures nothing but the size of their pupils.
Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
Mylan Laboratories Inc. has announced that the United States District Court for the Southern District of New York has ruled that Mylan's 10 mg and 20 mg omeprazole delayed-release capsules, which are the generic versions of AstraZeneca LP's Prilosec, do not infringe patents asserted against it by AstraZeneca.
› Verified 3 days ago
Provider Name | Manual Solutions Pllc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1659681534 PECOS PAC ID: 0244427292 Enrollment ID: O20101203000340 |
News Archive
Patients who are otherwise completely unable to communicate can answer yes or no questions within seconds with the help of a simple system-consisting of just a laptop and camera-that measures nothing but the size of their pupils.
Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
Mylan Laboratories Inc. has announced that the United States District Court for the Southern District of New York has ruled that Mylan's 10 mg and 20 mg omeprazole delayed-release capsules, which are the generic versions of AstraZeneca LP's Prilosec, do not infringe patents asserted against it by AstraZeneca.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Lindsay Ann Rankin, PT, DPT 780 E 1200 N, Shelley, ID 83274-5021 Ph: (801) 602-2651 | Lindsay Ann Rankin, PT, DPT 2785 Eagle Dr Apt G106, Ammon, ID 83406-5763 Ph: (801) 602-2651 |
News Archive
Patients who are otherwise completely unable to communicate can answer yes or no questions within seconds with the help of a simple system-consisting of just a laptop and camera-that measures nothing but the size of their pupils.
Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
Mylan Laboratories Inc. has announced that the United States District Court for the Southern District of New York has ruled that Mylan's 10 mg and 20 mg omeprazole delayed-release capsules, which are the generic versions of AstraZeneca LP's Prilosec, do not infringe patents asserted against it by AstraZeneca.
› Verified 3 days ago
Brittany Renae Brown, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1615 Curlew Dr, Ammon, ID 83406 Phone: 208-516-1204 Fax: 208-577-6477 | |
Peak Performance Therapy Services P C Physical Therapist Medicare: Medicare Enrolled Practice Location: 3456 E 17th St, Suite 130, Ammon, ID 83406 Phone: 208-523-0030 Fax: 208-523-3828 | |
Phares Briggs Horman, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3456 E 17th St, Suite 130, Ammon, ID 83406 Phone: 208-523-0030 | |
Vista Physical Therapy, Pllc Physical Therapist Medicare: Medicare Enrolled Practice Location: 1615 Midway Dr, Ammon, ID 83406 Phone: 208-529-1715 | |
Michael Cuthbertson, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3456 E 17th St Ste 130, Ammon, ID 83406 Phone: 208-523-0030 Fax: 208-523-3828 | |
Achieve Therapy And Learning Services, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 1979 Eagle Pointe Ct, Ammon, ID 83406 Phone: 208-589-8381 |